SA Transcripts • Aug. 10, 2013
We currently have no Breaking News on this stock.
GLPYY vs. ETF Alternatives
Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that... More
Other News & PR